⟵ Back to Search Results

BGB-A317/BGB-290_Study_001

Completed

The Safety, Pharmacokinetics and Antitumor Activity of BGB-A317 in Combination With BGB-290 in Participants With Advanced Solid Tumors

Beigene Study ID info

BGB-A317/BGB-290_Study_001

ClinicalTrials.gov ID info

NCT02660034

EudraCT Number info

2017-003580-35

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

Study Documents

Study Protocol Statistical Analysis Plan